Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

Accelerating synthetic chemistry with a predictive retrosynthesis solution

Posted on August 12th, 2021 by

AI & Data

In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical researchers typically start with a disease that they want to tackle, find a target, and then try to identify compounds which interact with that target. There may be around 200-300 drug candidates per project, and synthesis planning and execution usually takes four to eight weeks per drug candidate. This process requires many chemists and a huge, costly effort to proceed.

(more…)

Representation matters: Diversity in leadership

Posted on August 9th, 2021 by

Pharma R&D

Kumsal Bayazit, Elsevier CEO (Photo by Alison Bert)

We have known for some time now that having more women in leadership positions benefits companies, including their bottom line. This 2015 McKinsey report found that “Companies in the top quartile for gender diversity are 15 percent more likely to have financial returns above their respective national industry medians.” The same report also found that companies in the top quartile for racial and ethnic diversity are 35 percent more likely to see those higher financial returns.

(more…)

Technology and empathy help make remote working a success for Elsevier

Posted on July 29th, 2021 by

Pharma R&D

We at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this recent Comparably article. Like many organizations during the pandemic, we had to quickly adapt to remote working on a large scale for our international workforce. As the article notes, “Elsevier took an empathetic and pragmatic approach in supporting its people and its customers and rapidly harnessed technology to work from home.”

(more…)

World Hepatitis Day 2021

Posted on July 15th, 2021 by

Pharma R&D

Every 30 seconds, a person dies from a hepatitis-related illness. This terrible death toll is why the mantra for World Hepatitis Day (July 28) this year is “Hepatitis Can’t Wait”.

(more…)

How the Elsevier Foundation partnerships support sustainable development

Posted on July 7th, 2021 by

Chemistry

OWSD-Elsevier Foundation Awards for Early-Career Women Scientists in the Developing World award winners

Each year, the Elsevier Foundation gives over $1 million to an array of non-profit organizations. This support has gone to promising collaborations, STEM initiatives, leadership programs, technology platforms, early to mid-career scholars and more.

(more…)

Collecting DNA from thin air

Posted on July 2nd, 2021 by

Pharma R&D

In a proof-of-concept study published this spring, researchers revealed that animal DNA can be collected from air sampling. The study’s authors have dubbed this DNA “airDNA,” and it could open up a lot of possibilities for better understanding the world around us.

(more…)

  1. 1
  2. 2
  3. 3
  4. 4
  5. …
  6. 86

About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.